Sante Capital Fund’s NEVRO CORP. NVRO Stock Holding History

Sante Capital Fund’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,963	Closed	-$2.21M	–	27
2021 Q3	$2.21M	Buy	+18,963	New	+$2.48M	2.04%	13

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sante Capital Fund's NVRO Position: Q4 2021 in Review

Sante Capital Fund sold out of NEVRO CORP. (NVRO) in Q4 2021, closing a stake of 18,963 shares — an estimated $2.21M sold.

Sante Capital Fund first reported a position in NVRO in Q3 2021 and held it in 1 quarter. The position peaked at $2.21M in Q3 2021. 209 funds tracked by Wall St. Rank hold NVRO as of Q4 2021.

Sante Capital Fund reported no remaining NEVRO CORP. position as of Q4 2021 after selling out during the quarter.
Sante Capital Fund sold 18,963 NEVRO CORP. shares in Q4 2021, an estimated $2.21M.
Sante Capital Fund first reported a position in NEVRO CORP. in Q3 2021 and held it in 1 quarter.
Sante Capital Fund's NEVRO CORP. position peaked at $2.21M in Q3 2021.
209 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2021.

Based on Sante Capital Fund's 13F filing for Q4 2021.